The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $58.37

Today's change-0.19 -0.32%
Updated July 26 11:51 AM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $58.37

Today's change-0.19 -0.32%
Updated July 26 11:51 AM EDT. Delayed by at least 15 minutes.

Merck & Co Inc crosses below 20-day moving average

Merck & Co Inc is lower today, dropping (U.S.)$0.19 or 0.32% to (U.S.)$58.37 and crossing below its 20-day moving average. Shares have lost 0.49% over the last five days, but sit 2.83% below their 52-week high. This security has underperformed the S&P 500 by 2.52% during the last year.

Key company metrics

  • Open(U.S.) $58.70
  • Previous close(U.S.) $58.56
  • High(U.S.) $58.81
  • Low(U.S.) $58.18
  • Bid / Ask(U.S.) $58.36 / (U.S.) $58.37
  • YTD % change+10.51%
  • Volume2,458,835
  • Average volume (10-day)7,526,314
  • Average volume (1-month)9,664,931
  • Average volume (3-month)8,764,058
  • 52-week range(U.S.) $45.69 to (U.S.) $60.07
  • Beta0.66
  • Trailing P/E35.71×
  • P/E 1 year forward15.75×
  • Forward PEG3.09×
  • Indicated annual dividend(U.S.) $1.84
  • Dividend yield3.15%
  • Trailing EPS(U.S.) $1.63
Updated July 26 11:51 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.34%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue9,31210,21510,0739,785
Total other revenue--------
Total revenue9,31210,21510,0739,785
Gross profit5,7876,4466,3826,136
Total cost of revenue3,5253,7693,6913,649
Total operating expense7,6408,4967,8468,239
Selling / general / administrative2,3132,5602,4292,471
Research & development1,6041,7801,4831,655
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)198387243464
Other operating expenses, total--------
Operating income1,6721,7192,2271,546
Interest income (expense), net non-operating-172-169-165-174
Gain (loss) on sale of assets--------
Other--------
Income before tax1,6248162,397807
Income after tax1,1309821,831688
Income tax, total494-166566119
Net income1,1259771,826687
Total adjustments to net income--------
Net income before extra. items1,1259771,826687
Minority interest-5-5-5-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,1259771,826687
Inc. avail. to common incl. extra. items1,1259771,826687
Diluted net income1,1259771,826687
Dilution adjustment--------
Diluted weighted average shares2,7952,8142,8362,850
Diluted EPS excluding extraordinary itemsvalue per share0.400.350.640.24
Dividends per sharevalue per share0.460.460.450.45
Diluted normalized EPSvalue per share0.450.440.710.38